Alamose's Journal: FDA to use RFID

Bob Brewin writes:

"The FDA recently issued a draft Compliance Policy Guide that states that the agency will concentrate its tracking efforts on drugs that people are most likely to try to counterfeit or divert. They include drugs with high sales volumes, such as cholesterol-reducing Lipitor; expensive specialty drugs; and high-demand drugs, such as Tamiflu, whose use could skyrocket in a flu pandemic."

"The Food and Drug Administration will require drug manufacturers to track the distribution of high-priced drugs throughout the pharmaceutical supply chain beginning in December."

"The FDA will require the use of radio frequency identification technology, but it will not mandate RFID for tracking the sale of all prescription drugs by 2007, as the FDA had planned."